University of Arizona
Tucson, Arizona, 85721, United States
NCT Number: NCT00822510
The purpose of this project is to test a telephone delivered educational support program versus an education only program for improving symptom management and quality of life in men with prostate cancer and their partners.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 1
Tucson, Arizona, 85721, United States
Eligibility Criteria for men: receiving treatment for prostate cancer,over 21 years of age, English speaking, have access to and ability to talk on the phone and have a partner willing to participate in the study. Participants can live anywhere in the United States because the intervention is telephone delivered.
Partners can be anyone the man selects (friend or relative) who is over 21 years of age, English speaking and has access to or ability to speak on the phone.
Men and their partners will be assigned to one of two groups. Each survivor will receive 8 telephone calls over an 8-week period for about 30 minutes each. Each partner will receive 4 telephone calls every other week for about 30 minutes each. We will ask everyone to complete a baseline assessment over the telephone, after the 8 weeks, and then again about 8 weeks after the second assessment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Telephone delivered 8 week education and counseling intervention based on interpersonal psychotherapy.
Telephone delivered 8 week educational intervention on prostate cancer health, side effects, physical activity, diet, smoking cessation
Time frame: 3 points in time, baseline, T2=T1+8 weeks, T3=T2 plus 8 weeks
Depression was measured by the 20-item Center for Epidemiological Studies-Depression (CES-D) scale, Range is 0-60. Scores are added together with higher score greater depression.
Time frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
Perceived stress scale is a 10-item scale with a range of 0-40. Higher scores indicate more stress.
Time frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
Positive and Negative Affect Scale is a 20 item scale that measures positive and negative affect subscales. Scores range from 10-50 on each subscale with higher score indicating more positive affect.
Time frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
Positive and Negative Affect Scale is a 20 item scale that measures positive and negative affect subscales. Scores range from 10-50 on each subscale with higher score indicating more positive affect.
Time frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
Measure of physical well-being, specifically fatigue, using the Multidimensional Fatigue Scale. Scores range from 0-80 with higher scores indicative of more fatigue.
Time frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
Measures social well-being using the 9 item Social Well-being scale, ranging from 9-90. Higher score indicates increased social well-being.
Time frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
Measures if spiritual beliefs using a 7-item scale that ranges from 7-70. Higher score equals greater spiritual wellbeing.
University of Arizona
Other
Telephone Counseling With Men With Prostate Cancer and Partners
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03269422
Genital Diseases, Genital Diseases, Male
Basking Ridge, New Jersey, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03606837
Genital Diseases, Genital Diseases, Male
Bordeaux, France
View Trial DetailsNCT06540794
Genital Diseases, Genital Diseases, Male
Istanbul, Turkey (Türkiye)
View Trial Details